Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

Inclusion Criteria: * Hypertension patients who are taking an anti-hypertensive agent, including Fimasartan at least 12 weeks or more. * Dyslipidemia patients who are taking dyslipidemia drug, including Rosuvastatin at least 12 weeks or more * Patients who has blood pressure and lipid levels (Total cholesterol, LDL-C, HDL-C, non-HDL-C, \* TG) checks 2 weeks before registration Exclusion Criteria: * Patients being hospitalized * Patients who stop taking Fimasartan or Rosuvastatin within 12 weeks 14 or more consecutive days * Patients who have more than 400mg/dl triglyceride(TG) at the registration time